Integrated Biopharma Inc SEC filings INBP

Integrated Biopharma Inc has 557 filings in SEC EDGAR's recent list, going back to Nov 21, 1996. Its latest annual report, Form 10-K, was filed on Sep 25, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 8, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 25, 2026 (results of operations). The company's fiscal year ends on June 30.

Integrated Biopharma Inc SEC filings
Form Description Filed Period
DEF 14A Proxy statement Oct 28, 2026 Oct 28, 2026
8-K Current report
Results of operations
Sep 25, 2026 Sep 25, 2026
10-K Annual report Sep 25, 2026 Jun 30, 2026
8-K Current report
Other events
Aug 20, 2026 Aug 20, 2026
8-K Current report
Material agreement, Agreement ended
Jul 2, 2026 Jun 30, 2026
4/A Primary document Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
8-K Current report
Results of operations
May 8, 2026 May 8, 2026
10-Q Quarterly report May 8, 2026 Mar 31, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 17, 2026 —
SCHEDULE 13D Ownership over 5% (active) Apr 17, 2026 —
4/A Primary document Apr 17, 2026 Apr 15, 2026
4 Insider transaction Apr 17, 2026 Mar 24, 2026
4 Insider transaction Apr 17, 2026 Apr 15, 2026
4 Insider transaction Apr 17, 2026 Apr 15, 2026
8-K Current report
Other events
Apr 15, 2026 Apr 14, 2026
4 Insider transaction Mar 26, 2026 Mar 24, 2026
4 Insider transaction Mar 25, 2026 Mar 24, 2026
4 Insider transaction Mar 25, 2026 Mar 24, 2026
8-K Current report
Material agreement
Feb 18, 2026 Feb 17, 2026
8-K Current report
Results of operations
Feb 11, 2026 Feb 11, 2026
10-Q Quarterly report Feb 11, 2026 Dec 31, 2025
4 Insider transaction Dec 10, 2025 Dec 9, 2025
4 Insider transaction Dec 10, 2025 Dec 9, 2025
4 Insider transaction Dec 10, 2025 Dec 9, 2025
8-K Current report
Shareholder vote results
Dec 1, 2025 Dec 1, 2025
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
DEF 14A Proxy statement Oct 28, 2025 Oct 28, 2025
8-K Current report
Results of operations
Sep 23, 2025 Sep 23, 2025
10-K Annual report Sep 23, 2025 Jun 30, 2025
4 Insider transaction Jun 20, 2025 Jun 18, 2025
4 Insider transaction Jun 20, 2025 Jun 18, 2025
4 Insider transaction Jun 20, 2025 Jun 18, 2025
4 Insider transaction Jun 20, 2025 Jun 18, 2025
4 Insider transaction May 30, 2025 May 30, 2025
4 Insider transaction May 22, 2025 May 21, 2025
4 Insider transaction May 22, 2025 May 21, 2025
4 Insider transaction May 22, 2025 May 21, 2025
4 Insider transaction May 22, 2025 May 21, 2025
8-K Current report
Results of operations
May 14, 2025 May 14, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Auditor change
Apr 24, 2025 Apr 24, 2025
8-K Current report
Material agreement, Agreement ended, New debt
Apr 21, 2025 Apr 15, 2025
8-K Current report
Results of operations
Feb 13, 2025 Feb 13, 2025
10-Q Quarterly report Feb 13, 2025 Dec 31, 2024
4 Insider transaction Dec 5, 2024 Dec 4, 2024
4 Insider transaction Dec 5, 2024 Dec 4, 2024
4 Insider transaction Dec 5, 2024 Dec 4, 2024
8-K Current report
Shareholder vote results
Dec 2, 2024 Dec 2, 2024
4 Insider transaction Nov 25, 2024 Nov 25, 2024
4 Insider transaction Nov 25, 2024 Nov 25, 2024
4 Insider transaction Nov 25, 2024 Nov 25, 2024
8-K Current report
Results of operations
Nov 14, 2024 Nov 13, 2024
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
DEF 14A Proxy statement Oct 28, 2024 Oct 28, 2024
8-K Current report
Results of operations
Sep 23, 2024 Sep 20, 2024
10-K Annual report Sep 20, 2024 Jun 30, 2024
4 Insider transaction Aug 8, 2024 Aug 7, 2024
4 Insider transaction Aug 8, 2024 Aug 7, 2024
4 Insider transaction Aug 8, 2024 Aug 7, 2024
4 Insider transaction Aug 8, 2024 Aug 7, 2024
8-K Current report
Results of operations
May 10, 2024 May 10, 2024
10-Q Quarterly report May 10, 2024 Mar 31, 2024
8-K Current report
Results of operations
Feb 12, 2024 Feb 12, 2024
10-Q Quarterly report Feb 12, 2024 Dec 31, 2023
4 Insider transaction Nov 29, 2023 Nov 28, 2023
4 Insider transaction Nov 29, 2023 Nov 28, 2023
4 Insider transaction Nov 29, 2023 Nov 28, 2023
8-K Current report
Shareholder vote results
Nov 27, 2023 Nov 27, 2023
SC 13D Ownership over 5% (active) Nov 16, 2023 —
5 Annual insider ownership Nov 16, 2023 Jun 30, 2023
3 Initial insider ownership Nov 16, 2023 Mar 20, 2023
SC 13D Ownership over 5% (active) Nov 14, 2023 —
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
DEF 14A Proxy statement Oct 27, 2023 Oct 27, 2023
4 Insider transaction Sep 21, 2023 May 25, 2023
4 Insider transaction Sep 21, 2023 May 25, 2023
4 Insider transaction Sep 21, 2023 Sep 20, 2023
8-K Current report
Results of operations
Sep 15, 2023 Sep 15, 2023
10-K Annual report Sep 15, 2023 Jun 30, 2023
4 Insider transaction Jul 20, 2023 Jul 18, 2023
4 Insider transaction Jul 19, 2023 Jul 18, 2023
4 Insider transaction Jul 19, 2023 Jul 18, 2023
4 Insider transaction Jul 19, 2023 Jul 18, 2023
4 Insider transaction Jun 1, 2023 May 30, 2023
4 Insider transaction Jun 1, 2023 May 30, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Other events
Mar 21, 2023 Mar 20, 2023
8-K Current report
Material agreement
Mar 17, 2023 Mar 16, 2023
8-K Current report
Results of operations
Feb 10, 2023 Feb 10, 2023
10-Q Quarterly report Feb 10, 2023 Dec 31, 2022
8-K Current report
Material agreement
Dec 6, 2022 Dec 1, 2022
8-K Current report
Shareholder vote results
Nov 28, 2022 Nov 28, 2022
8-K/A Amended current report
Results of operations
Nov 14, 2022 Nov 10, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 10, 2022
4 Insider transaction Nov 10, 2022 Nov 9, 2022
4 Insider transaction Nov 10, 2022 Nov 9, 2022
4 Insider transaction Nov 10, 2022 Nov 9, 2022
4 Insider transaction Nov 10, 2022 Nov 9, 2022
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
DEF 14A Proxy statement Oct 27, 2022 Nov 28, 2022
8-K Current report
Auditor change
Oct 24, 2022 Oct 21, 2022
8-K Current report
Results of operations
Sep 14, 2022 Sep 13, 2022
10-K Annual report Sep 13, 2022 Jun 30, 2022
8-K Current report
Material agreement, Agreement ended
Jul 15, 2022 Jul 15, 2022
4 Insider transaction Jun 21, 2022 Jun 20, 2022
3 Initial insider ownership Jun 21, 2022 Jun 20, 2022
8-K Current report
Officer or director change
Jun 21, 2022 Jun 20, 2022
4 Insider transaction Jun 21, 2022 Jun 20, 2022
4 Insider transaction Jun 21, 2022 Jun 20, 2022
4 Insider transaction Jun 21, 2022 Jun 20, 2022
8-K Current report
Results of operations
May 12, 2022 May 11, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
4/A Primary document May 11, 2022 May 6, 2022
4 Insider transaction May 6, 2022 May 6, 2022
8-K Current report
Results of operations
Feb 10, 2022 Feb 10, 2022
10-Q Quarterly report Feb 10, 2022 Dec 31, 2021
8-K Current report
Shareholder vote results
Nov 29, 2021 Nov 29, 2021
8-K Current report
Results of operations
Nov 10, 2021 Nov 10, 2021
10-Q Quarterly report Nov 10, 2021 Sep 30, 2021
4 Insider transaction Nov 4, 2021 Nov 3, 2021
4 Insider transaction Nov 4, 2021 Nov 3, 2021
4 Insider transaction Nov 4, 2021 Nov 3, 2021
4 Insider transaction Nov 3, 2021 Nov 3, 2021
4 Insider transaction Nov 3, 2021 Nov 3, 2021
4 Insider transaction Nov 3, 2021 Nov 3, 2021
4 Insider transaction Nov 3, 2021 Nov 3, 2021
4 Insider transaction Nov 3, 2021 Nov 3, 2021
DEF 14A Proxy statement Oct 27, 2021 Oct 27, 2021
8-K Current report
Results of operations
Sep 2, 2021 Sep 2, 2021
10-K Annual report Sep 2, 2021 Jun 30, 2021
8-K Current report
Agreement ended
Jul 7, 2021 Jun 30, 2021
8-K Current report
Results of operations
May 13, 2021 May 13, 2021
10-Q Quarterly report May 13, 2021 Mar 31, 2021
8-K Current report
Other events
Apr 8, 2021 Apr 8, 2021
8-K Current report
Results of operations
Feb 12, 2021 Feb 12, 2021
10-Q Quarterly report Feb 12, 2021 Dec 31, 2020
8-K Current report
Other events
Jan 22, 2021 Jan 22, 2021
8-K Current report
Shareholder vote results
Nov 30, 2020 Nov 30, 2020
4 Insider transaction Nov 20, 2020 Nov 4, 2020
4 Insider transaction Nov 20, 2020 Nov 4, 2020
4 Insider transaction Nov 20, 2020 Nov 4, 2020
4 Insider transaction Nov 20, 2020 Nov 4, 2020
4 Insider transaction Nov 20, 2020 Nov 4, 2020
4 Insider transaction Nov 20, 2020 Nov 4, 2020
4 Insider transaction Nov 20, 2020 Nov 4, 2020
4 Insider transaction Nov 20, 2020 Nov 4, 2020
3 Initial insider ownership Nov 17, 2020 Nov 4, 2020
8-K Current report
Results of operations
Nov 12, 2020 Nov 12, 2020
10-Q Quarterly report Nov 12, 2020 Sep 30, 2020
8-K Current report
Officer or director change
Nov 9, 2020 Nov 4, 2020
DEF 14A Proxy statement Oct 28, 2020 Oct 28, 2020
8-K Current report Sep 24, 2020 Sep 23, 2020
10-K Annual report Sep 23, 2020 Jun 30, 2020
8-K Current report
Results of operations
May 14, 2020 May 13, 2020
10-Q Quarterly report May 13, 2020 Mar 31, 2020
8-K Current report
Results of operations
Feb 12, 2020 Feb 12, 2020
10-Q Quarterly report Feb 12, 2020 Dec 31, 2019
8-K Current report
Shareholder vote results
Dec 3, 2019 Dec 2, 2019
8-K Current report
Results of operations
Nov 13, 2019 Nov 13, 2019
10-Q Quarterly report Nov 13, 2019 Sep 30, 2019
DEF 14A Proxy statement Oct 28, 2019 Oct 28, 2019
8-K Current report
New debt
Sep 16, 2019 Sep 16, 2019
10-K Annual report Aug 29, 2019 Jun 30, 2019
4 Insider transaction May 29, 2019 May 24, 2019
4 Insider transaction May 29, 2019 May 24, 2019
4 Insider transaction May 29, 2019 May 24, 2019
4 Insider transaction May 29, 2019 May 24, 2019
4 Insider transaction May 29, 2019 May 24, 2019
4 Insider transaction May 29, 2019 May 24, 2019
4 Insider transaction May 29, 2019 May 24, 2019
8-K Current report
Officer or director change
May 29, 2019 May 22, 2019
8-K Current report
Results of operations
May 15, 2019 May 15, 2019
10-Q Quarterly report May 15, 2019 Mar 31, 2019
8-K Current report
Officer or director change
May 6, 2019 May 1, 2019
10-Q Quarterly report Feb 13, 2019 Dec 31, 2018
S-8 Employee stock plan registration Dec 28, 2018 —
4/A Primary document Dec 19, 2018 Dec 19, 2018
4/A Primary document Dec 19, 2018 Dec 19, 2018
4 Insider transaction Dec 19, 2018 Dec 19, 2018
4 Insider transaction Dec 19, 2018 Dec 19, 2018
4 Insider transaction Dec 19, 2018 Dec 19, 2018
8-K Current report
Shareholder vote results
Nov 26, 2018 Nov 26, 2018
10-Q Quarterly report Nov 9, 2018 Sep 30, 2018
DEF 14A Proxy statement Oct 29, 2018 Nov 26, 2018
10-K Annual report Sep 12, 2018 Jun 30, 2018
4 Insider transaction Aug 1, 2018 Jul 31, 2018
4 Insider transaction Aug 1, 2018 Jul 31, 2018
4 Insider transaction Aug 1, 2018 Jul 31, 2018
8-K Current report
Agreement ended, Unregistered share sale
Aug 1, 2018 Jul 31, 2018
10-Q Quarterly report May 9, 2018 Mar 31, 2018
10-Q Quarterly report Feb 9, 2018 Dec 31, 2017
8-K Current report
Shareholder vote results
Nov 28, 2017 Nov 27, 2017
10-Q Quarterly report Nov 9, 2017 Sep 30, 2017

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
INBP (OTC)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Hillside, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1016504
Former names
INTEGRATED HEALTH TECHNOLOGIES INC (until Apr 16, 2003); CHEM INTERNATIONAL INC (until May 14, 2002)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.